Page
Real World Evidence
READ MORE
Page
Clinical Development
READ MORE
Page
Clinical Trial Supply
READ MORE
Page
Early Access Programs
READ MORE
Page
Our Approach to Rare
READ MORE
Page
Patient Advocacy
READ MORE
Page
A Career with Purpose
READ MORE
Press Room
Tom Watson appointed Chief Executive Officer
READ MORE
Press Room
Bionical Emas launches Expanded Access Program for JZP458 – a recombinant Erwinia Asparaginase
READ MORE
Press Room
Bionical Emas launches Managed Access Program for JZP 458 – a recombinant Crisantaspase produced in Pseudomonas fluorescens
READ MORE
Press Room
Bionical Emas and Jazz Pharmaceuticals Enter into an Agreement for Expanded Access to Lurbinectedin in Relapsed Small Cell Lung Cancer in the United States
READ MORE
Press Room
Women In Healthcare – PharmaTimes May 2020
READ MORE
3 / 6